OBJECTIVES: Suture line disruption is a serious complication after aortic surgery. We previously reported in a canine model that basic fibroblast growth factor-incorporated biodegradable polyglycolic acid (PGA) felt prevented tissue derangement at the anastomotic site. This study sought to evaluate the safety and durability of this biodegradable felt.
Safety and durability of the biodegradable felt in aortic surgery: a propensity score-matched study † 
INTRODUCTION
Since Cooley and DeBakey [1] first reported the successful repair of a thoracic aortic aneurysm in 1956, significant advances have resulted in lower operative mortality and better long-term outcomes for aortic surgery. Consequently, the number of patients at risk for late complications has increased. In addition, notable improvements on the quality of imaging modalities such as echocardiography and computed tomography (CT) have greatly aided in precisely identifying abnormalities that meet the indication for reoperation. Suture line disruption between the native aorta and prosthetic vascular grafts is a rare but serious immediate and late complication after aortic surgery. One of the presumed causes is anastomotic compliance mismatch due to the suturing and/or graft materials [2] . Although using absorbable suture materials reportedly enables to improve compliance [3] [4] [5] , this technique has not gained wide acceptance for fear of the long-term insecurity of the suture line. In fact, a possible risk of suture line disintegration, even after using non-absorbable suture materials resulted in pseudoaneurysm formation, has been reported [6] [7] [8] . Polytetrafluoroethylene (PTFE) felt is a standard material for reinforcing aortic anastomotic sites; however, it is also considered to be associated with inherent limitations including chronic compression of the aortic wall [9] and compliance mismatch [10] , resulting in anastomotic aneurysms in 2-3% of aortic surgeries [11] [12] [13] . Although the reinforcement of the anastomotic site appears reasonable during the acute postoperative period, once the successive biological reaction of the tissue has been settled down, reinforcement is no longer considered necessary. Accordingly, we hypothesized that biodegradable material is optimal for reinforcing the anastomoses to eliminate the disadvantages of conventional felts and providing some expedient effects on late outcomes. Polyglycolic acid (PGA) felt is an unwoven structure composed of an ultrathin biodegradable material. This material was reported to be thoroughly hydrolysed in 3-4 months under in vivo conditions [14] [15] [16] . In addition to this biodegradable material, we attempted to use basic fibroblast growth factor (bFGF), which is a powerful angiogenic growth factor that promotes tissue repair [17] . Although its in vivo half-life is extremely short [18] , Tabata et al. [19] [20] [21] [22] reported that bFGF release can be controlled effectively via incorporation into gelatine hydrogels. In a previous canine study, we identified differences in the structural changes that occur at anastomosed aortic walls with different materials; in particular, reinforcement with the PTFE felt was associated with thinning of the media and adventitia and a small number of vessels in the adventitia. In contrast, these histological changes did not occur when the bFGF-incorporated PGA felt was used [23] . Suture line loosening or pseudoaneurysm formation was not observed. Considering these beneficial findings, we sought to validate the safety and durability of the bFGF-incorporated PGA felt as a reinforcement material for aortic anastomoses.
MATERIALS AND METHODS

Patients
After the ethics committee of our institution approved the study protocol [application number 2007-298], we conducted a prospective single-arm clinical study of 67 patients who consented to undergo aortic surgery using the PGA felt in the Division of Cardiothoracic Surgery at Tohoku University Hospital between January 2007 and December 2011 (Group P). The exclusion criteria were emergent case, stent graft surgery, active infection and autoimmune disease (e.g. aortitis and Behcet's disease). As a control, we retrospectively reviewed the charts of 129 patients who underwent aortic surgery using the PTFE felt during the same registration period (Group N). Group N include the patients who were unwilling to participate in this study or the patients who underwent surgery when the bFGF-incorporated PGA felt was not available due to limited supply.
Preparation of the basic fibroblast growth factor-incorporated polyglycolic acid felt Gelatine hydrogels were prepared as previously described [24] ( Fig. 1) . Briefly, 400 ml of glutaraldehyde aqueous solution (25 wt%; Wako Pure Chemical Industries, Osaka, Japan) and 200 ml of 5 wt% gelatine aqueous solution (Type I collagen, with an isoelectric point of 5.0, extracted from bovine bone using the alkaline method; Nitta Gelatin, Osaka, Japan) were heated up to 40 C, and the PGA felt strip (10 mm Â 100 mm; Gunze Co, Kyoto, Japan), which was pretreated with corona discharge supplied with 100 V for 1 min to enhance gelatine binding, was soaked in the mixed aqueous solution for 12 h at 4 C to promote crosslinking. Thereafter, the PGA felt strip was immersed in 50-mM glycine (Wako Pure Chemical Industries) aqueous solution at 37 C for 1 h to block the residual aldehyde groups of glutaraldehyde, rinsed 3 times with double-distilled water at 37 C and freeze-dried. The dried PGA felt strip was finally sterilized using ethylene oxide gas.
Commercial aqueous recombinant human bFGF solution (10 mg/ml, with an isoelectric point of 9.6; Kaken Pharmaceutical, Tokyo, Japan) was diluted using double-distilled water to adjust the concentration to 50 mg/ml. Before intraoperative use, 0.2 ml/kg bFGF solution was dropped onto the freeze-dried gelatine hydrogel-coated PGA felt strip, followed by incubation for 1 h at 25 C to allow the bFGF solution to completely soak into the gelatine hydrogel.
Operative procedure
In the scheduled aortic surgery, the anastomotic sites between the prosthetic graft and native aorta were reinforced circumferentially using the bFGF-incorporated PGA felt in Group P and the PTFE felt (porosity, 1700 ml/min/cm 2 /H 2 O; Kouno Co., Chiba, Japan) in Group N. The anastomoses were made using a 3-0 or 4-0 polypropylene over-and-over running suture (Prolene V R ; Ethicon, Inc., A Johnson & Johnson Company, Somerville, NJ, USA). The size of the felt strip was 10 mm Â 100 mm in all cases. The types of prosthetic vascular grafts were chosen according to each surgeon's preference.
Follow-up
Contrast CT was performed to evaluate the aortic morphology before discharge in all surviving patients. During the follow-up period at the outpatient clinic, contrast CT was performed every 6-12 months for most patients. The anastomotic pseudoaneurysm was diagnosed as aneurysmal dilatation corresponding to the anastomotic site and unable to ensure the intact vascular wall structure. For the evaluation of anastomotic dilatation, the diameter of the native aorta adjacent to the anastomotic site was measured using CT (Fig. 2) . The change in diameter was calculated as the dilatation ratio [(post-discharge diameter -predischarge diameter)/predischarge diameter Â 100 (%)]. CT measurements were performed in a blinded manner based on the clinical information. 
Data analysis
The primary end-points were mortality and freedom from aortic events including anastomotic pseudoaneurysm, redo aortic surgery, prosthetic graft-related infection and bleeding complications. Categorical variables are presented as frequencies and percentages, and continuous variables are expressed as the mean ± standard deviation.
Matching between the 2 groups was performed using the propensity score analysis. Propensity scores were developed on the basis of 18 covariates in a logistic regression model with aortic surgery using the bFGF-incorporated PGA felt as the dependent variable. Variables that could affect patient survival were used as covariates, namely age, gender, renal impairment, peripheral arterial disease, poor mobility, i.e. severe impairment of mobility secondary to musculoskeletal or neurological dysfunction, history of previous surgery, chronic obstructive pulmonary disease, diabetes, New York Heart Association (NYHA) functional classification, left ventricular ejection fraction, number of intended surgical procedures, body mass index, smoking, hypertension, dyslipidaemia, Marfan syndrome, aetiology of aneurysm and intended surgical approach. One-to-one matching, a nearest neighbour algorithm and a calliper of 0.20 were used for the matching process. Units outside common support were discarded for both groups. An independent-samples Student's t-test or Mann-Whitney U-test were used for group comparisons of continuous variables, and the v 2 test or the Fisher's exact test were used for group comparisons of categorical variables. For the matched pair comparison, the paired t-test for continuous variables and the McNemar's test for categorical variables were used. All reported P-values were 2-sided, and P-value <0.05 was considered statistically significant. The median follow-up time was computed using the inverse Kaplan-Meier method, whereas survival estimates and rates of freedom from aortic events were calculated using the KaplanMeier method. Differences between groups were quantified using the log-rank test. All statistical analyses were performed using JMP version 11.0 (SAS Institute Inc., Cary, NC, USA).
RESULTS
Baseline characteristics and postoperative outcomes in the original cohort
The baseline characteristics of the original cohort are summarized in Table 1 . In Group P, the mean patient age was 59.3 ± 16.6 years, and 20.9% of the patients were women. Regarding the aneurysmal pathology, degenerative aneurysms, dissecting aneurysms and pseudoaneurysms were identified in 35 (52.2%), 25 (37.3%) and 7 (10.5%) patients, respectively. Concerning the surgical approach, a median sternotomy was performed in 33 (49.3%) patients, whereas a left lateral thoracotomy was performed in 34 (50.8%) patients.
Intraoperative profiles and postoperative outcomes are summarized in Table 2 . In Group P, the descending thoracic or thoraco-abdominal aortic repair was performed in 34 (50.8%) patients. No patients required mechanical circulatory support postoperatively. There were 2 hospital deaths, and the overall hospital mortality rate was 3.0%. One patient died due to sepsis on postoperative Day 89, and another died because of gastrointestinal haemorrhage on postoperative Day 5. Three (4.5%) patients needed re-exploration for bleeding; however, no cases of bleeding were related to the use of the PGA felt. During a mean of 5.5 years of follow-up, an anastomotic pseudoaneurysm occurred in 1 patient 1 month after total arch replacement. The bleeding point was an enlarged needle hole on the native aorta at the proximal anastomotic site in the ascending aortic position, which was repaired with a pledgetted buttress suture. All of these postoperative outcomes showed no statistically significant difference when compared with those of Group N.
Baseline characteristics and postoperative outcomes in propensity score-matched pairs Sixty well-matched pairs of patients were identified using propensity score matching and classified into Groups P and N, and the clinical indices were compared. The concordance index was 0.71. Preoperative patient characteristics did not differ between the 2 groups ( Table 3) .
As summarized in Table 4 , the operative data did not differ between the groups. The descending thoracic or thoracoabdominal aortic repair was performed in 28 (46.7%) patients in Group P and 30 (50%) patients in Group N. Concerning postoperative outcomes, the in-hospital mortality rates were 3.3% (2 patients) in Group P and 8.3% (5 patients) in Group N, and the difference was not statistically significant. Only 1 patient in Group N needed mechanical circulatory support postoperatively, and the intergroup difference was not significant. Re-explorations for bleeding were performed in 3 (5%) patients in Group P and 6 (10%) patients in Group N, and the difference was not significant. During 5.6 and 4.2 years of follow-up in Groups P and N, respectively, 1 patient in each group experienced an anastomotic pseudoaneurysm.
Late outcomes in propensity score-matched pairs
The median follow-up duration was 5.6 years with a range from 4.3 to 6.5 years in Group P and 4.2 years with a range from 3.5 to 6.0 years in Group N. As shown in Fig. 3 , the overall survival rates at 2 and 5 years were 91% and 86%, respectively, in Group P and 88% and 81% in Group N, respectively. Late survival according to the Kaplan-Meier analysis was not significantly different (P = 0.42). In the overall cohort of Group P, there were 8 cases of late death. Of these, 3, 1 and 4 patients died of malignancy, stroke and unknown causes, respectively. The 2-and 5-year aortic event-free rates were 93% and 86% in Group P and 91% and 82% in Group N, respectively. No differences were identified between the groups using the Kaplan-Meier analysis (P = 0.99). In the overall cohort of Group P, 10 patients experienced aorticrelated complications; of whom, 1 patient underwent a redo surgery for pseudoaneurysm as mentioned previously, 1 patient underwent an emergent surgery due to acute aortic dissection, 1 patient underwent re-exploration due to the left inter-thoracic haematoma and 7 patients underwent a redo surgery due to dilatation of a portion of the aorta that was not targeted in the previous surgery.
As further surveillance, we measured the diameter of the native aorta adjacent to the anastomotic site via CT. Most of the PGA felts could not be detected distinctly in the CT images in the late phase, whereas the PGA felts were depicted slightly more faintly than the PTFE felts in CT images in the acute phase. These findings suggested that the PGA felts used for anastomotic reinforcement were completely degraded by the late phase. In total, 65 anastomoses in 48 patients of Group P and 54 anastomoses in 42 patients of Group N were assessed with a median follow-up of 5.8 and 5.0 years, respectively. The dilatation ratio of Group P (2.5 ± 0.5%) was significantly lower than that of Group N (4.3 ± 0.6%, P = 0.01).
DISCUSSION
We have validated the safety and durability of the bFGF-incorporated PGA felt as a reinforcement material for aortic anastomoses by demonstrating statistically insignificant difference in aorticevent-free rate as that for the conventional PTFE felt in this propensity-matched patient cohort study. In addition, we demonstrated that the dilatation ratio of the native aorta adjacent to the anastomotic site over the long term was smaller in the biodegradable felt group than in the PTFE group, indicating that the ameliorated local aortic dilatation might be, at least in part, related to biodegradable reinforcing material reconciling the compliance mismatch at the anastomotic site.
At present, the PTFE felt strips are widely used to ensure haemostasis and reinforce the anastomotic site in aortic surgery. However, after the tissue has healed completely at the anastomotic site, reinforcement materials can be detrimental because of chronic compression of the tissue or compliance mismatch. Thus, the reinforcing material is needed for only a short period. From this viewpoint, we designed the clinical investigation of the bFGF-incorporated PGA felt, which is designed to supply the needed reinforcing strength during the acute phase, promote tissue healing at the anastomotic site, dissolve in the late phase and decrease the occurrence of anastomotic aneurysms.
In this study, 1.5% of patients who underwent aortic surgery with the PGA felt experienced anastomotic pseudoaneurysms in the late phase, which was similar to the rates of 2-3% in previous reports [11] [12] [13] . Similarly, the incidence of bleeding events in patients who underwent surgery using the PGA felt did not differ significantly from that of patients who underwent surgery using the PTFE felt. Previously, we demonstrated that the implanted PGA felt was gradually replaced by fibrous tissue in the process of hydrolysation in a canine descending thoracic aortic replacement model [23] . We speculate that this fibrogenesis prevents loosening of the suture line even after the felt is completely dissolved. In addition, bFGF is inferred to promote fibrogenesis. The previous study demonstrated that the bFGF-incorporated PGA felt accelerated angiogenesis at the tunica externa of the anastomotic site [23] . With 5% gelatine, as used in this study, it is known that bFGF is released over an approximately 1-month period [25] . This continuous release of bFGF may have contributed to the robustness of the anastomoses in this study.
Although glutaraldehyde was used in the process of coating the PGA felt with a gelatine hydrogel and the residual aldehyde groups were blocked by glycine at a later step of preparation, there were no complications, suggesting the lack of cytotoxicity of the bFGF-incorporated PGA felt. Rather, the use of the bFGFincorporated PGA felt may help to prevent prosthetic graft infection via its enhanced neovascularization capacity. We previously demonstrated that enhanced perigraft angiogenesis induced by bFGF could inhibit bacterial colonization in a rat model [26] . Despite the lack of differences in the incidence of mediastinal or left intrathoracic infection in this study, further follow-up is warranted to elucidate the impact of bFGF-induced angiogenesis at the aortic anastomotic site.
The reported prevalence of anastomotic dilatation/paraanastomotic true aneurysms ranges from 1% to 7% [27] [28] [29] . The CT examination of this study revealed that the bFGF-incorporated PGA felt significantly attenuated dilatation of the anastomotic site. In almost all cases, the PGA felt could not be recognized on long-term CT images. Although it is unclear whether this observed anastomotic dilatation leads to subsequent aneurysmal formation because the dilatation rate in the present cohort was extremely low, this finding might illustrate the beneficial effect of the biodegradable nature of the PGA felt, which eliminates chronic compression of the anastomotic site and compliance mismatch. In addition, as mentioned previously, the possible anti-infective property of the bFGF-incorporated PGA felt may be helpful in preventing prosthetic graft infection, which is known as one of the common risk factors promoting the development of anastomotic aneurysms.
Limitations
Several limitations of this study warrant consideration. This investigation was subject to the limitations inherent in nonrandomized studies, although the lack of randomization was partly compensated by propensity score matching. The nature of single-arm prospective studies may have affected the results because of unmeasured confounders, procedural bias or detection bias. Randomization is more helpful in considering these potential confounding factors. As the occurrence rate of anastomosis-related adverse events was not high, the follow-up duration may not have been sufficient to detect differences in late outcomes between the 2 groups. Several patients were lost to follow-up in both groups, which may have affected the late outcomes. We must continue monitoring these patients. In addition, a longer follow-up using additional CTs might elucidate whether dilatation of the vascular anastomosis continues to increase at the same rate in both groups. The end-point diameter of the juxta-anastomotic aortic dilation was a post hoc finding; therefore, it could be a incidental finding. In this study, we could not present histological data for the anastomotic site, as we have not encountered a patient from whom tissue from the anastomotic site could be obtained for histopathological examination. As we did not set the group of the PGA felt without bFGF, we were unable to clarify the additional effect of bFGF, albeit already validated in our previous canine experiment [23] . Because this study population did not include patients who underwent acute aortic dissection, it needs to be addressed in the further study to evaluate the efficacy of the bFGF-incorporated PGA felt in acute dissections procedures, in which the aortic tissue is more fragile and inflammative. Also, we did not evaluate the synergistic effect of the simultaneous use of surgical tissue adhesives including BioGlue V R (CryoLife, Kennesaw, GA, USA) with the PGA felt, although several reports have demonstrated the favourable effect of the PGA felt with fibrin glue in other types of surgeries [30] . This study represents the experience of a single large tertiary referral centre, and the results may not be generalizable to other centres.
CONCLUSION
In conclusion, regarding the safety and durability, no statistically significant differences were found between the bFGF-incorporated PGA felt and conventional felt for reinforcement in aortic surgery. In addition, the attenuation of juxta-anastomotic aortic dilatation by the PGA felt reinforcement may provide more beneficial effects on long-term outcomes. Further studies are warranted to clarify the substantial efficacy of the bFGF-incorporated PGA felt in aortic surgery.
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